SCHEMBL28577667

SCHEMBL28577667

CC(C(=O)O)N(C)C(=O)C1(N)CCCC1

nearest known ligand 0.33

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
MME P08473 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6224526 0.74 NSD2 (0.30)
SCHEMBL5522534 0.73 MEN1 (0.34)
SCHEMBL11794573 0.71 TSHR (0.30)
SCHEMBL19406478 0.71 MEN1 (0.37)
SCHEMBL21267725 0.70
SCHEMBL7432173 0.70 TSHR (0.33)
Cycloleucine SCHEMBL27714107 0.68 NSD2 (0.38)
Cycloleucine SCHEMBL3230571 0.68 NSD2 (0.38)
SCHEMBL27274994 0.68 LMNA (0.33)
Trifluoroacetic Acid SCHEMBL2496292 0.67 TACR1 (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107903303-B Liquid phase synthesis method of cyclopeptide Alaptide 陕西慧康生物科技有限责任公司 2021-06-04 CN claimed